SOX2 and Claudin-4 Are Useful Marker for Differentiating the Undifferentiated Uterine Carcinoma From the Recently Recognized SMARCA4 (BRG1)-Deficient Malignant Rhabdoid Tumor of Uterus

LABORATORY INVESTIGATION(2019)

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要